Clenbuterol to Target DUX4 in FSHD

NCT06721299 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Muscular Dystrophy, Facioscapulohumeral

Interventions

DRUG: Clenbuterol

Sponsor

Jeffrey Statland

Collaborators

[object Object]
[object Object]
[object Object]